Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers
Despite recent advances in molecularly targeted therapies and immunotherapies, the
effective treatment of advanced-stage cancers remains a largely unmet clinical need …
effective treatment of advanced-stage cancers remains a largely unmet clinical need …
[HTML][HTML] Gastrointestinal organoids: How they gut it out
The gastrointestinal tract is characterized by a self-renewing epithelium fueled by adult stem
cells residing at the bottom of the intestinal crypt and gastric glands. Their activity and …
cells residing at the bottom of the intestinal crypt and gastric glands. Their activity and …
ASPM promotes prostate cancer stemness and progression by augmenting Wnt− Dvl-3− β-catenin signaling
VC Pai, CC Hsu, TS Chan, WY Liao, CP Chuu… - Oncogene, 2019 - nature.com
Recurrent and hormone-refractory prostate cancer (PCA) exhibits aggressive behaviors
while current therapeutic approaches show little effect of prolonging the survival of patients …
while current therapeutic approaches show little effect of prolonging the survival of patients …
Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis
L Zhou, Y Du, L Kong, X Zhang… - OncoTargets and therapy, 2018 - Taylor & Francis
Background and aim Hepatocellular carcinoma (HCC) is a major cause of cancer mortality
and is increasing incidence worldwide. The aim of this study was to identify the key genes …
and is increasing incidence worldwide. The aim of this study was to identify the key genes …
ASPM promotes hepatocellular carcinoma progression by activating Wnt/β‐catenin signaling through antagonizing autophagy‐mediated Dvl2 degradation
H Zhang, X Yang, L Zhu, Z Li, P Zuo, P Wang… - FEBS Open …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most fatal cancers worldwide. In this article,
we show that expression of abnormal spindle‐like microcephaly‐associated protein (ASPM) …
we show that expression of abnormal spindle‐like microcephaly‐associated protein (ASPM) …
Impact of cancer stem cells on therapy resistance in gastric cancer
M Otaegi-Ugartemendia, A Matheu, E Carrasco-Garcia - Cancers, 2022 - mdpi.com
Simple Summary Therapy resistance represents one of the major obstacles to curing cancer.
Particular populations of tumor cells, known as cancer stem cells, are responsible for this …
Particular populations of tumor cells, known as cancer stem cells, are responsible for this …
[HTML][HTML] ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling
X Chen, L Huang, Y Yang, S Chen, J Sun, C Ma… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Increasing evidence has indicated that the disorganized expression of certain genes
promotes tumour progression. In this study, we elucidate the potential key differentially …
promotes tumour progression. In this study, we elucidate the potential key differentially …
[HTML][HTML] Co-expression network analysis identified gene signatures in osteosarcoma as a predictive tool for lung metastasis and survival
Osteosarcoma (OS) is the most common primary bone tumor, whose poor prognosis is
mainly due to lung metastasis. The aim of this study is to build a practical and valid …
mainly due to lung metastasis. The aim of this study is to build a practical and valid …
CCKBR+ cancer cells contribute to the intratumor heterogeneity of gastric cancer and confer sensitivity to FOXO inhibition
Z Tan, K Pan, M Sun, X Pan, Z Yang, Z Chang… - Cell Death & …, 2024 - nature.com
The existence of heterogeneity has plunged cancer treatment into a challenging dilemma.
We profiled malignant epithelial cells from 5 gastric adenocarcinoma patients through single …
We profiled malignant epithelial cells from 5 gastric adenocarcinoma patients through single …
A multi-mode Wnt-and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer
CC Hsu, WY Liao, KY Chang, TS Chan, PJ Huang… - Gastric Cancer, 2021 - Springer
Background Gastric cancer (GC) is the third leading cause of cancer mortality globally and a
molecularly heterogeneous disease. Identifying the driver pathways in GC progression is …
molecularly heterogeneous disease. Identifying the driver pathways in GC progression is …